DXCM | DexComNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$82.97
-$1.79 (-2.11%)

DexCom (DXCM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $82.97 vs 50 $85.51 / 200 $74.71
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 Jun 2026 ยท projected 25 bars out ยท tested 2 bars

Weekly as of 30 Oct 16:00 ET

Price
between the two $82.29 vs 50 $73.15 / 200 $91.57
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 14 Oct 2024 ยท projected 7 bars out

Cross history

26
crosses on record since 2018
13 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
29 Jun 2026Golden moderatedaily25 bars out2 bar cross test
9 Jun 2026Golden4-hour27 bars outNot tested
2 Apr 2026Death4-hour18 bars out2 bar cross test
15 Jan 2026Golden4-hour24 bars outNot tested
22 Sep 2025Death moderatedaily22 bars outNot tested

About DXCM

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$315M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.